Publication
Managing a corporation in a pandemic: How directors and officers can fulfill their duties and limit risk
Canada | Publication | March 30, 2020 - 12 PM ET
For many corporations, the extraordinary circumstances triggered by the COVID-19 pandemic have materially changed the situation at hand. As such, determining the corporation’s best interests may involve a more complex analysis. This is particularly so where the interest of shareholders in value maximization may run counter to the interests of other stakeholders, such as employees.
Business judgment rule
How do directors and officers satisfy this increasingly challenging duty and minimize their exposure to personal liability? The answer begins with good governance and processes that ensure due consideration of stakeholder interests. If directors and officers follow best practices and processes in this regard, under the “business judgment rule” Canadian courts are more likely to be deferential to their decisions so long as the decisions lie within a range of reasonable alternatives.The specific forms of governance and decision-making processes that should be followed will vary depending upon the nature of the corporation’s business. In general, noting the situation at hand, directors should be asking tough questions, including about the viability of the corporation’s business model, the need for additional or modified disclosure (for instance, guidance on revenue), management’s crisis management plans, compliance with contractual covenants (for instance, debt covenants), newly available contractual rights (for instance, the right to declare force majeure), new supply chain risks, employee safety, and any newly available government assistance.
In this particular situation at hand, directors and officers should consider the availability of expert advice on COVID-19 issues, and in any event stay on top of COVID-19 developments, including changes to laws and government programs. The need for more frequent board meetings and management reports should also be considered.
In terms of personal exposure, directors and officers should also seek advice on the adequacy of the corporation’s D&O insurance coverage and their rights of indemnity, and pay close attention to corporate tax obligations that can lead to personal liability.
We also refer the reader to the Norton Rose Fulbright publications:
- Managing Securities litigation risks in the age of uncertainty
- COVID-19: Legal considerations for Canadian boards
Recent publications
Publication
The GCR Guide to Life Sciences – Product denigration
Marta Giner Asins and Arnaud Sanz of our Paris office are the authors of a chapter on product denigration that has been published in the third edition of the Global Competition Review’s The Guide to Life Sciences.
Publication
The GCR Guide to Life Sciences – Merger control: Procedural issues
Miranda Cole, Julien Haverals and Emma Clarke of our Brussels/ London offices are the authors of a chapter on procedural issues in merger control that has been published in the third edition of the Global Competition Review’s The Guide to Life Sciences. This covers a number of significant procedural developments that have affected merger review of life sciences transactions.
Subscribe and stay up to date with the latest legal news, information and events . . .